短时动态[18F]DCFPyL PET与CT灌注成像定位前列腺癌优势病灶:组织病理验证及与120分钟PET/MR比较
本研究以前列腺癌根治术后全mount数字组织病理为参考,验证22分钟动态[18F]DCFPyL PET和CT灌注(CTP)定位优势前列腺内病灶(DIL)的性能,并与注射后2小时PET/MR比较。15例患者分析显示,SUVLate与联合Ki和k4的动力学模型区分DIL与非DIL体素的AUC均为0.90、错误率<10%,检测DIL的平均Dice系数分别为0.7和0.8。短时动态[18F]DCFPyL PET在该诊断任务中不劣于SUVLate。
要点
- 22分钟动态[18F]DCFPyL PET动力学参数可准确定位前列腺癌DIL。
- SUVLate与Ki+k4模型区分DIL的AUC均为0.90,错误率<10%。
- 短时动态PET定位DIL不劣于SUVLate,可用于靶向活检与放疗。
核心结论
- 经配准数字组织病理验证,22分钟动态[18F]DCFPyL PET动力学参数能准确定位前列腺癌DIL,用于靶向活检、放疗和局灶消融。
- 短时动态[18F]DCFPyL PET在该诊断任务中不劣于SUVLate。
研究设计与样本
- 患者根治性前列腺切除术前采集T2w-MRI、22分钟动态[18F]DCFPyL PET/CT、CTP及注射后2小时PET/MR。
- 离体腺体植入基准标记后行T2w-MRI,所有图像以基准标记和解剖标志配准至病理医师标注的全mount中腺组织切片数字图像。
- 在数字病理图像上勾画DIL与非DIL组织感兴趣区并叠加至PET与CTP参数图,采用逻辑回归后退法筛选参数,并行留一患者交叉验证评估诊断性能。
主要发现
- 分析15例患者的[18F]DCFPyL PET与CTP参数图。
- SUVLate及联合[18F]DCFPyL的Ki与k4的模型区分DIL与非DIL体素最准确,两者AUC均为0.90、错误率<10%。
- 与数字组织病理相比,Ki与k4模型检测DIL的平均Dice相似系数为0.8,SUVLate为0.7。
关键数值与推荐
- SUVLate与Ki+k4模型区分DIL与非DIL体素的AUC均为0.90,错误率均<10%。
- Ki+k4模型检测DIL的平均Dice相似系数为0.8,SUVLate为0.7。
临床怎么用
- 短时动态[18F]DCFPyL PET动力学参数可用于前列腺癌DIL定位,辅助靶向活检、放疗和局灶消融治疗规划。
- 在该诊断任务中短时动态[18F]DCFPyL PET不劣于SUVLate,提示无需依赖延迟显像即可定位DIL。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Localized prostate cancer (PCa) in patients is characterized by a dominant focus in the gland (dominant intraprostatic lesion, DIL). Accurate DIL identification may enable more accurate diagnosis and therapy through more precise targeting of biopsy, radiotherapy and focal ablative therapies. The goal of this study is to validate the performance of [18F]DCFPyL PET and CT perfusion (CTP) for detecting and localizing DIL against digital histopathological images. METHODS: Multi-modality image sets: in vivo T2-weighted (T2w)-MRI, 22-min dynamic [18F]DCFPyL PET/CT, CTP, and 2-h post-injection PET/MR were acquired in patients prior to radical prostatectomy. The explanted gland with implanted fiducial markers was imaged with T2w-MRI. All images were co-registered to the pathologist-annotated digital images of whole-mount mid-gland histology sections using fiducial markers and anatomical landmarks. Regions of interest encompassing DIL and non-DIL tissue were drawn on the digital histopathological images and superimposed on PET and CTP parametric maps. Logistic regression with backward elimination of parameters was used to select the most sensitive parameter set to distinguish DIL from non-DIL voxels. Leave-one-patient-out cross-validation was performed to determine diagnostic performance. RESULTS: [18F]DCFPyL PET and CTP parametric maps of 15 patients were analyzed. SUVLate and a model combining Ki and k4 of [18F]DCFPyL achieved the most accurate performance distinguishing DIL from non-DIL voxels. Both detection models achieved an AUC of 0.90 and an error rate of < 10%. Compared to digital histopathology, the detected DILs had a mean dice similarity coefficient of 0.8 for the Ki and k4 model and 0.7 for SUVLate. CONCLUSIONS: We have validated using co-registered digital histopathological images that parameters from kinetic analysis of 22-min dynamic [18F]DCFPyL PET can accurately localize DILs in PCa for targeting of biopsy, radiotherapy, and focal ablative therapies. Short-duration dynamic [18F]DCFPyL PET was not inferior to SUVLate in this diagnostic task. CLINICAL TRIAL REGISTRATION NUMBER: NCT04009174 (ClinicalTrials.gov).
引用
- Yang DM, Alfano R, Bauman G, et al. Short-duration dynamic [18F]DCFPyL PET and CT perfusion imaging to localize dominant intraprostatic lesions in prostate cancer: validation against digital histopathology and comparison to [18F]DCFPyL PET/MR at 120 minutes. EJNMMI Res. 2021. PMID: 34652551. doi:10.1186/s13550-021-00844-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。